AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...
Johnson & Johnson's Tecvayli has been approved as part of a combination regimen with its Genmab-partnered Darzalex Faspro as a second-line therapy for relapsed or refractory multiple myeloma, just 55 ...
These five AI image-editing prompts can help improve backgrounds, outfits, headshots, product photos, and image quality across today’s top tools. Apple If you can only read one tech story a day, this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results